New molecular targets and biological therapies in sarcomas

Cancer Treatment Reviews
F A Scappaticci, N Marina

Abstract

The treatment of patients with soft tissue and bone sarcomas has dramatically improved over the last decade. This improvement has been brought about through advances in diagnosis, surgical techniques, conformal radiotherapy, and combination chemotherapy. Further advances in the management of the diverse spectrum of sarcoma patients will reflect tailoring of therapy based on molecular abnormalities. The role of cytogenetics and molecular analysis of fusion or mutated genes in diagnosis, prognosis, and design of biological treatments is discussed. An example of this approach has been the recent success in treatment of patients with gastrointestinal stromal tumours expressing mutant c-kit with a specific tyrosine kinase inhibitor, STI571. Molecular rearrangements may also serve as targets for designing specific immunotherapies with the fusion gene product. The use of biological therapies with signal transduction inhibitors, angiogenesis inhibitors, matrix metalloproteinase inhibitors, immunotherapy, differentiation inducers, and gene therapy could complement existing treatments for long-term control of disease. As these newer biological agents take form, clinical trial design will undergo change to reflect the chronic nature of th...Continue Reading

References

Nov 1, 1992·Genes, Chromosomes & Cancer·J Whang-PengT Triche
May 28, 1992·The New England Journal of Medicine·R A EzekowitzJ Folkman
Nov 1, 1991·Genes, Chromosomes & Cancer·E C DouglassH M Maurer
Mar 15, 1990·Nature·N HeisterkampJ Groffen
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M A KelliherN Rosenberg
Sep 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A EliasK H Antman
Dec 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T A Alvegård, N O Berg
Apr 1, 1986·Cancer Genetics and Cytogenetics·J Whang-PengM A Israel
Jan 15, 1988·Cancer·H M MaurerJ Ortega
Jun 19, 1986·The New England Journal of Medicine·M P LinkJ A Kirkpatrick
Jan 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F EilberJ Goodnight
Nov 18, 1971·The New England Journal of Medicine·J Folkman
Apr 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A ZoubekH Kovar
Jan 15, 1997·The Biochemical Journal·N M HooperA J Turner
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·C L WilsonL M Matrisian
May 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K M KellyF G Barr
Jan 1, 1997·Investigational New Drugs·S M Wojtowicz-PragaM J Hawkins
Aug 8, 1997·Biochimica Et Biophysica Acta·A D Cox, C J Der
Jan 1, 1997·Investigational New Drugs·L J Denis, J Verweij
Dec 6, 1997·Nature·R S Kerbel
Jan 4, 1998·Journal of Pediatric Hematology/oncology·F G Barr
Mar 28, 1998·Blood Cells, Molecules & Diseases·C Gambacorti-PasseriniN B Lydon
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E de AlavaM Ladanyi
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Wojtowicz-PragaM J Hawkins
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·J Folkman
Oct 27, 1998·Journal of Pediatric Hematology/oncology·K M KellyF G Barr
Jan 23, 1999·Nature Genetics·P O Brown, D Botstein
Mar 5, 1999·Breast Cancer Research and Treatment·P D Brown

❮ Previous
Next ❯

Citations

Jul 24, 2003·The Journal of Molecular Diagnostics : JMD·Chung-Che Chang, Vinod B Shidham
Dec 1, 2004·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Jinyoung YooChang Suk Kang
Feb 9, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jaap Verweij, Laurence H Baker
Apr 19, 2005·Genes, Chromosomes & Cancer·Kevin J AshtonLyn R Griffiths
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Natacha Entz-WerléAnnie Babin-Boilletot
Sep 14, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frank A Scappaticci
Jun 21, 2008·Clinical Orthopaedics and Related Research·Balaji KrishnanDenis Clohisy
Sep 17, 2002·The Journal of Psychology·Melissa A Meade, Natasha Slesnick
Sep 25, 2017·The Oncologist·Michael J NathensonEdward Sausville
Mar 15, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·John R PetersenDeborah A Payne
Apr 30, 2005·La Presse médicale·M L BeyroutiA Ghorbel

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.